1138:HKEXDgenx Co., Ltd. Analysis
Data as of 2026-05-31 - not real-time
₩600.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Dgenx Co., Ltd. (1138) is trading at KRW 600, well below its DCF‑derived fair value of approximately KRW 1,098, indicating a substantial valuation gap. Technical indicators are bearish: the price sits under the 20‑day (670.75), 50‑day (712.3) and 200‑day (796.3) moving averages, the MACD line (-27.42) is below its signal (-23.32) and the RSI of 29.98 suggests oversold conditions but without clear reversal momentum. Volume is on a decreasing trend and the stock is hovering just above its identified support at KRW 590, with resistance near KRW 738, while volatility remains high at 59% over the past 30 days. Fundamentally, revenue has fallen 25% year‑over‑year, margins are thin (gross 12.1%, operating -6.6%, profit 0.9%), and the company carries a debt‑to‑equity ratio of 65% despite holding KRW 11.46 bn in cash, raising concerns about leverage. The dividend yield of 2.51% appears attractive, yet the payout ratio is effectively zero and earnings per share are nil, questioning sustainability. Market sentiment is extremely bullish (Fear‑Greed Index 94), but the stock’s beta of 0.45 signals limited sensitivity to broader market moves. Overall, the combination of a deep valuation discount, weak operating performance, and heightened short‑term technical pressure suggests caution, while the long‑run upside potential remains tied to a possible turnaround or strategic repositioning.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below all major moving averages
- Bearish MACD and decreasing volume
- Proximity to support level with high volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation gap to DCF fair value
- Strong cash position offset by high debt
- Uncertain earnings recovery despite dividend yield
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Potential upside if operational turnaround occurs
- Undervaluation relative to intrinsic value
- Low beta suggesting limited market‑wide downside exposure
Key Metrics & Analysis
Financial Health
Revenue Growth-24.90%
Profit Margin0.92%
ROE2.47%
ROA0.59%
Debt/Equity65.02
Op. Cash Flow₩3.3B
Free Cash Flow₩3.0B
Technical Analysis
TrendBearish
RSI30.0
Support₩590.00
Resistance₩738.00
MA 20₩670.75
MA 50₩712.30
MA 200₩796.30
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Fair Value₩1,098.35
GradeUndervalued
TypeValue
Dividend Yield2.51%
Risk Assessment
Beta0.45
Volatility59.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.